That is necessary, since the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. In other words, we need to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (legacy report prediction). And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're created to do. This was a breakthrough almost no one observed. But it's going to have extensive implications for treating disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of investment chances in this space, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown 2021 stock predictions). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back possibly significantly prior to going greater - last year. I've been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mostly informing readers. But that's not the big concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. genetic sequencing companies jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous terrific personal business on the brink of striking the public markets And I have actually been working on a brand-new method for you to invest even before these business go public.
This chance has actually been constructing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to book your area free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our normal beat (biotech stocks). And when it comes to tech investing, we leave it to the experts. The good news is, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we know (melania trump). In fact, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These patterns are experiencing rapid development and creating extraordinary chances for financiers. I desire to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. biotech stocks. But in spite of what many readers may believe, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown predictions for 2021). Losing two months of manufacturing and sales really affects how numerous 5G gadgets are sold in the calendar year. When you consider all of that, selling 250 million units is amazing. More importantly, the hold-ups caused by the pandemic developed a lots of bottled-up demand. And that demand is now going to be pushed into 2021. In fact, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown biotech picks. And that's not my only 5G prediction When I have actually discussed 5G in the past, I have actually explained its 3 various phases.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Stage Three, 5G services start to be used (jeff brown biotech genome sequencing). That's when we start to see applications running on 5G networks. Believe of things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage Three by this summer. This starts something of a virtuous cycle: The majority of people don't really appreciate the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open a suite of unbelievable applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment chances moving forward will be huge. Stepping away from 5G, the next crucial technology I anticipate in 2021 is CRISPR genetic editing. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software application.
The program can crash or not work correctly. CRISPR utilizes a comparable idea however with our genetic code. "Typos" in our genome can lead to illness. CRISPR can correct these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And throughout that time, there were really only three companies operating in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with diseases and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This whole market is effectively a greenfield chance.
There's room for many companies to exist in this space. self-driving cars. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can properly anticipate the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That's important since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been an experimental procedure. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced using this innovation. This was one of those breakthroughs that practically nobody saw. However it's going to have profound ramifications for treating illness. And, obviously, there will be plenty of financial investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps substantially prior to going higher. I've been covering bitcoin for a long period of time now. One of the very first research reports I ever released was on bitcoin - toxic tech 5 tech darlings. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my suggestion. However at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. exponential tech investor. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date since February 2021, but we could not separately validate this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this minute. Brown is best known for his sage-like ability to select winning technology stocks. He spent more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent viewpoint on the market. He's always on the hunt for new opportunities, and he shares much of his best choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully anticipated a few of the most significant economic occasions of the past twenty years. Although he does not appear to launch his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it ideal whenever, however Jeff Brown's accurate predictions have actually made him legions of devoted fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent financial research study publisher. Brownstone Research study offers a number of research study services with a wide range of specializations - jeff brown prediction for 2021.
The business is also associated with Bonner & Partners, another well-respected research publisher - first lady. On its site, Brownstone states its objective is to provide retail financiers with professional-grade research study: "For too long, the best investment research has not been readily available to private investors. It has been usually reserved for investment banks, hedge funds, personal equity, and high-net-worth customers. what is the legacy report predicting. The objective of Brownstone Research study is to make that sort of proprietary research study available to any financiers seeking to get an edge in the marketplaces. The objective is simple to provide unique and profitable investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the firm's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After decades of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you understand even a bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown stock predictions. Whatever he touches turns to gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown thinks S.A.V. jeff brown genetic sequencing stock. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 advanced innovations: expert system and electric vehicles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving cars ever. It's absolutely nothing brief of the automotive market's Holy Grail. As you know, electrical vehicles and self-driving vehicle stocks have actually been big this year, but the Wall Street machine has approved buzz without much concrete result. Regardless of an extreme increase in competitors over the past couple of years, Brown still thinks Musk has the very best possibility of putting everything together.
tech might be the magic string that connects it all together. S.A.V. represents Shared Autonomous Vehicle, and it could be the future of transport. Generally, this technology would permit you to rent your car as a self-governing, self-driving taxi when you're not utilizing it. You just get out of the cars and truck and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial chunk of the earnings. It sounds crazy, however it could be closed than you believe.